Adaptive laboratory evolution resolves energy depletion to maintain high aromatic metabolite phenotypes in <i>Escherichia coli </i>strains lacking the Phosphotransferase System by McCloskey, Douglas et al.
 
 
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright 
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
 Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
 You may not further distribute the material or use it for any profit-making activity or commercial gain 
 You may freely distribute the URL identifying the publication in the public portal 
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
  
 
   
 
 
Downloaded from orbit.dtu.dk on: Oct 21, 2019
Adaptive laboratory evolution resolves energy depletion to maintain high aromatic
metabolite phenotypes in Escherichia coli strains lacking the Phosphotransferase
System
McCloskey, Douglas; Xu, Sibei; Sandberg, Troy E.; Brunk, Elizabeth; Hefner, Ying; Szubin, Richard;
Feist, Adam M.; Palsson, Bernhard O.
Published in:
Metabolic Engineering
Link to article, DOI:
10.1016/j.ymben.2018.06.005
Publication date:
2018
Document Version
Peer reviewed version
Link back to DTU Orbit
Citation (APA):
McCloskey, D., Xu, S., Sandberg, T. E., Brunk, E., Hefner, Y., Szubin, R., ... Palsson, B. O. (2018). Adaptive
laboratory evolution resolves energy depletion to maintain high aromatic metabolite phenotypes in Escherichia
coli strains lacking the Phosphotransferase System. Metabolic Engineering, 48, 233-242.
https://doi.org/10.1016/j.ymben.2018.06.005
Author’s Accepted Manuscript
Adaptive laboratory evolution resolves energy
depletion to maintain high aromatic metabolite
phenotypes in Escherichia coli strains lacking the
Phosphotransferase System
Douglas McCloskey, Sibei Xu, Troy E. Sandberg,
Elizabeth Brunk, Ying Hefner, Richard Szubin,
Adam M. Feist, Bernhard O. Palsson
PII: S1096-7176(18)30017-X
DOI: https://doi.org/10.1016/j.ymben.2018.06.005
Reference: YMBEN1425
To appear in: Metabolic Engineering
Received date: 17 January 2018
Revised date: 8 June 2018
Accepted date: 9 June 2018
Cite this article as: Douglas McCloskey, Sibei Xu, Troy E. Sandberg, Elizabeth
Brunk, Ying Hefner, Richard Szubin, Adam M. Feist and Bernhard O. Palsson,
Adaptive laboratory evolution resolves energy depletion to maintain high
aromatic metabolite phenotypes in Escherichia coli strains lacking the
Phosphotransferase System, Metabolic Engineering,
https://doi.org/10.1016/j.ymben.2018.06.005
This is a PDF file of an unedited manuscript that has been accepted for
publication. As a service to our customers we are providing this early version of
the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting galley proof before it is published in its final citable form.
Please note that during the production process errors may be discovered which
could affect the content, and all legal disclaimers that apply to the journal pertain.
www.elsevier.com/locate/ymben
1 
 
Adaptive laboratory evolution resolves energy depletion to maintain high aromatic metabolite 
phenotypes in Escherichia coli strains lacking the Phosphotransferase System 
Douglas McCloskey1,2, Sibei Xu1, Troy E. Sandberg1, Elizabeth Brunk1, Ying Hefner1, Richard 
Szubin1, Adam M. Feist1,2, , and Bernhard O. Palsson1,2,* 
 
1Department of Bioengineering, University of California - San Diego, La Jolla, CA 92093, USA. 
2Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800 
Lyngby, Denmark. 
*Corresponding author, Department of Bioengineering, University of California, San Diego, 9500 
Gilman Drive, La Jolla, CA 92093-0412, USA. Tel.: [858-534-5668]; Fax: [858-822-3120]; E-
mail: palsson@ucsd.edu 
 
Abstract 
Aromatic metabolites provide the backbone for numerous industrial and pharmaceutical 
compounds of high value.   The Phosphotransferase System (PTS) is common to many 
bacteria, and is the primary mechanism for glucose uptake by Escherichia coli.  The PTS was 
removed to conserve phosphoenolpyruvate (pep), which is a precursor for aromatic metabolites 
and consumed by the PTS, for aromatic metabolite production.  Replicate adaptive laboratory 
evolution (ALE) of PTS and detailed omics data sets collected revealed that the PTS bridged 
the gap between respiration and fermentation, leading to distinct high fermentative and high 
respiratory rate phenotypes.  It was also found that while all strains retained high levels of 
aromatic amino acid (AAA) biosynthetic precursors, only one replicate from the high glycolytic 
clade retained high levels of intracellular AAAs. The fast growth and high AAA precursor 
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phenotypes could provide a starting host for cell factories targeting the overproduction aromatic 
metabolites. 
Subject terms  
Adaptive laboratory evolution, mutation analysis, multi-omics analysis, systems biology, E. coli, 
ptsH, ptsI, and crr gene knockouts 
 
 
Introduction 
Aromatic metabolites provide the backbone for numerous nutraceuticals, pharmaceuticals, 
solvents, polymers, and a plethora of other commodity and fine chemical products 1–6.  Aromatic 
metabolites are derived from the shikimate pathway where glycolytic and pentose phosphate 
pathway (PPP) intermediates phosphoenolpyruvate (pep) and erythrose 4-phosphate (e4p) are 
combined and aromatized to chorismate (chor).  Chor forms the building blocks for numerous 
aromatic compounds including the three aromatic amino acids (AAAs) L-tyrosine (tyr-L), L-
phenylalanine (phe-L), and L-tryptophan (trp-L).  Decades of research has focused on 
engineering cell factories for increased biosynthesis of AAAs and their intermediates in the 
hopes of developing a high aromatic compound producing strain from renewable resources 1–29. 
 
The primary route of glucose import in E. coli is via the Phosphotransferase System (PTS) 7,10,13.  
The PTS is shared by many bacteria 30.  The PTS imports and phosphorylates carbon sources 
(such as glucose) while converting Phosphoenolpyruvate (pep) to Pyruvate (pyr), thus 
consuming one of two moles (i.e., 50%) of pep produced by glycolysis. Strategies to conserve 
phosphoenolpyruvate for aromatic compound production include removal of ptsH, ptsI, and crr 
genes to disable the PTS.  This forces the cell to utilize ATP-dependent glucose import 
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mechanisms, which causes an energy drain leading to slow growth 1,8.  Engineering strategies 
are thus required to not only improve glucose utilization, but do so while conserving ATP.  While 
strategies have been found, more optimal strategies, and a deeper understanding of the 
mechanisms of successful strategies would be greatly beneficial. 
 
 
Instead of brute force and combinatorial optimization of genetic interventions that is typical of 
most metabolic engineering workflows, this study employed an alternative strategy whereby the 
PTS was removed from a pre-optimized E. coli strain, and evolution was allowed to select for 
solutions to improve the glucose import and growth phenotype of the ptsHIcrr strain.  Novel 
solutions were found that allowed for both fast growth and high intracellular AAAs as well as 
their precursors.  Key was the regeneration of energy in the absence of carbon source 
activation by pep.  This lead to distinct high glycolytic and high respiratory rate phenotypes.  In 
addition to the generation of beneficial strains for biotechnology applications, the in depth multi-
omics characterization of this study brings together biochemical details on a highly valued 
phenotype that can be utilized for further optimization. 
Results 
ptsH, ptsI, and crr KOs and ALE 
A wild-type E. coli K-12 MG1655 strain previously evolved under glucose minimal media at 37°C 
31 (denoted as “Ref”) was selected in order to minimize biological changes caused by adaption 
to the loss of a gene product from those caused by adaption to the growth conditions of the 
experiment.   GLCptspp (genes ptsH, ptsI, and crr corresponding to enzymes HPr, EI, and EIIA, 
respectively) were removed from Ref to generate strain uPtsHIcrr (denoted “unevolved ptsHIcrr 
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knockout strain”).  The loss of ptsH, ptsI, and crr disabled the PTS and resulted in a 79% loss in 
fitness (Fig. 1B).  Four uPtsHIcrr independently inoculated starting cultures were simultaneously 
evolved on glucose minimal media at 37°C in an automated ALE platform 31,32 denoted “evolved 
ptsHIcrr knockout strains” or “ePtsHIcrr”.  A statistically significant increase in final fitness 
(Student’s t-test, pvalue<0.05) was found in all ALE endpoints of the ePtsHIcrr lineages 
(ave±stdev 259±74% increase in fitness) compared to uPtsHIcrr.   
Conservation of pep initially translated to high aromatic amino 
acid levels 
Inactivation of the PTS increased the availability of phosphoenolpyruvate (pep) for aromatic 
amino acid (AAA) biosynthesis by dissociating glucose import from pep consumption (Fig. 2A,B) 
1,5.  LC-MS/MS 33,34 was used to quantify the levels of pep and AAAs.  The levels of pep in 
uPtsHIcrr were 853.6% greater than Ref (Fig. 2C, Fig. S1, Table S3).  High intracellular pep 
translated to high levels of AAA pathway intermediates (Fig. S1) as well as the AAAs L-tyrosine 
(tyr-L), L-phenylalanine (phe-L), and L-tryptophan (trp-L), which were 99.9, 90.5, and 49.1% 
greater in uPtsHIcrr than in Ref, respectively.  Synthesis of the AAAs, is a linear pathway 
starting from erythrose 4-phosphate (e4p) and pep to the AAA intermediate chorismate (chor) 
where it then branches out to each of the three AAAs (Fig. S2).  The loss of the PTS system 
thus imbalanced AAA levels as a result of the high level of pep that could not be converted to 
pyruvate in the unevolved KOs strain. 
 
Adaptive evolution led to partial abrogation of this imbalance. High intracellular levels of AAAs 
were lost in all ePtsHIcrr strains except for phe-L and tyr-L in ePtsHIcrr03  (Fig. 2C,Table S3).   
Levels of phe-L waned to a 51.9% increase over Ref, while levels of tyr-L shot up to a 626.6% 
increase over Ref.  These results raised two questions: first, what were the mechanisms by 
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which the ePtsHIcrr strains were able to recover growth and glucose import?  And second, why 
was the high AAA phenotype lost in all strains except for ePtsHIcrr03?  To answer these 
questions, DNA resequencing, RNA sequencing, fluxomics, and further metabolomics data were 
collected and analyzed for all strains. 
Loss of the PTS inactivated carbon catabolite repression (CCR) 
via cAMP 
Evidence for strong activation of carbon catabolite repressed operons by cAMP-CRP was 
revealed by transcriptional profiling.  Alternative glucose import and catabolism systems 
including glucokinase, the D-galactose symporter, and D-galactose ABC transporter were 
upregulated in uPtsHIcrr compared to Ref (Fig. 3C, Table S4).  In particular, genes encoding the 
galactitol and D-sorbital PTS were upregulated in uPtsHIcrr compared to Ref.  These genes are 
positively regulated primarily by CRP-cAMP due to an insertion of IS3E in the gatR gene 35, and 
serve as a proxy for cAMP-CRP activation status. 
 
CRP activity is modulated by intracellular levels of its activator, cAMP.  Highly elevated levels of 
cAMP were found in uPtsHIcrr compared to Ref (Fig. 4C, Table S3).  The increased levels of 
cAMP and the activation of cAMP-CRP positively regulated genes indicated that a rise in 
intracellular cAMP levels in uPtsHIcrr inactivated CCR while in the presence of high levels of 
glucose.  This observation is non-intuitive because phosphorylated EIIA (encoded by crr) 
stimulates Adenylate Cyclase (AC, encoded by cyaA) to convert ATP to cAMP 36 (Fig. 3A).  The 
uPtsHIcrr strain lacks crr.  In addition, cAMP-CRP represses cyaA expression 37, which was 
found to lead to a significant decrease in cyaA expression in uPtsHIcrr.  Previous studies have 
hypothesized that low levels of cAMP should be found in ptsHIcrr- strains 14,38 due to decreased 
AC activity and decreased cyaA expression as highlighted above.  By directly measuring cAMP, 
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this study demonstrates that it can be produced at high levels in the absence of EIIA and at low 
cyaA expression levels due to the presence of an unknown activator  39,40.   
Truncation of AC altered expression of CCR associated genes 
Mutations in cyaA were found in ePtsHIcrr 01/03 that appeared to silence the activation of 
cAMP-CRP positively regulated genes that were found in ePtsHIcrr (Fig. 4).  Deletion (DEL) at 
the 456 residue in ePtsHIcrr01 and mobile element insertion (MOB) at the 518 residue in 
ePtsHIcrr03 truncated the peptide at the EIIA binding domain of AC (Fig. 4B).  ePtsHIcrr01 and 
ePtsHIcrr03 had the lowest levels of cAMP compared to Ref, uPtsHIcrr, and the other ePtsHIcrr 
strains.  This demonstrated that another effector was capable of stimulating AC activity at the 
EIIA binding domain besides the gene product of crr 39,40, and that a physiological advantage 
could be had by removing the ability of that effector to bind AC.   
 
The reduced levels of cAMP in ePtsHIcrr01/03 resulted in down regulation of many CCR 
operons.  These included genes encoding the D-galactose ABC transporter, galactitol and D-
sorbital PTS, and D-ribose symporter (Fig. 4C).  However, genes encoding the D-galactose 
symporter and D-galactose catabolism remained significantly elevated in ePtsHIcrr01/03 
compared to Ref.  This indicated that passive import and catabolism of glucose via D-galactose 
symporters paired with increased ATP production from overflow metabolism 41 (Fig. 1D) was 
sufficient to help restore glucose import capabilities in ePtsHIcrr01/03 strains 3,8.  In contrast, 
mutations in ATP-dependent glucose importers were found in ePtsHIcrr02/04 strains (discussed 
below). 
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Loss of PTS shifted glucose import towards symporters 
Inactivation of the PTS required a shift to alternative importers in order to enable glucose import 
in uPtsHIcrr.   Genome-scale MFA 42,43 was used to measure the fluxes into and out of the pep 
node (Fig. 5).  In Ref, 100% of  flux per mol of glucose imported was phosphorylated by the 
PTS.  In contrast, 100% of flux per mol of imported glucose was taken up by alternative glucose 
importers and then phosphorylated by hexokinase (HEX1) in uPtsHIcrr and ePtsHIcrr strains. 
Expression profiling revealed that the primary glucose importer in uPtsHIcrr was via the D-
galactose symporter, encoded by galP with subsequent phosphorylation by hexokinase, 
encoded by glk (Fig. 2A-B, Fig. 5C, Table S4).  Previous studies have demonstrated that the D-
galactose symporter has affinity for glucose, and that upregulation of galP and glk significantly 
increase glucose import at the expense of ATP 3,8. 
Mutations in alternative importers helped to restore glucose 
import capacity 
Initial upregulation of galP and glk was insufficient to restore glucose import capacity in 
uPtsHIcrr relative to  the ref strains (Fig. 1D).  In contrast to ePtsHIcrr01/03 where mutations 
targeted cAMP-CRP regulation, as discussed above, mutations that directly targeted sugar 
transport and catabolism operons appeared in ePtsHIcrr02/04.  Affected genes included galR 
(Fig. 6) and nagC (Fig. 7).      
 
Mutations at the galP TF binding site and in galR in ePtsHIcrr02 and 04, respectively, altered 
regulation of the D-galactose symporter (galP) and D-galactose ABC transporter (mglBAC) by 
inhibiting the ability of operon-specific regulators, GalS and GalR, to repress expression (Fig. 6). 
An SNP in galR occurred in the small molecule binding domain that appeared to diminish the 
ability of effectors to activate GalR (Fig. 6A).  ePtsHIcrr04 had the highest expression of 
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galETKM and mglBAC compared to all other strains.  An SNP in galP targeted the GalR and 
GalS TF binding sites that appeared to negate repression by GalR and GalS (Fig. 6B).  
ePtsHIcrr02 had the highest expression of galP compared to all other strains.   
 
A mutation in nagC in ePtsHIcrr04 altered regulation nAcGam catabolic genes (nagBAC) and 
nAcGam PTS component EIIB-nAcGam (nagE) (Fig. 7).  NagC is a TF that inhibits expression 
of nagBAC and nagE operons.  nagE encodes the PTS-import component that takes in 
exogenous N-acetylglucosamine (nAcGam) that is derived either from turnover of the cell wall or 
found in the environment at the expense of pep.  Note that nAcGam was not supplemented in 
the culture medium.  Enzymes encoded by nagA and nagB then break down nAcGam to 
acetate, ammonia, and D-fructose-6-phosphate.  The mutation occurred away from the DNA 
binding site and may affect the ability of effectors to active NagC.  ePtsHIcrr04 had the highest 
expression of nagBAC and nagE compared to all other strains. 
Non-PTS glucose import and phosphorylation caused an energy 
drain 
The use of alternative glucose importers shifted the phosphoryl donor of g6p from pep to ATP 
due to the reliance upon HEX1 to convert glucose to g6p (Fig. 2 and Fig. 5).  Reliance upon 
ATP-dependent phosphorylation of glucose resulted in a reduction in ATP and an elevation of 
AMP amounting to a significant reduction in the energy charge in uPtsHIcrr (Fig. 2C, Table S3).  
The energy drain caused by decreased availability of energy equivalents contributed to a 
decreased growth rate  in uPtsHIcrr 3,22,44 (Fig. 1D).   
 
The activity of HEX1 was directly addressed by two of the four ePtsHIcrr strains.  An intergenic 
mutation in front of the glk transcription start site in ePtsHIcrr02/04 appeared to downregulate 
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expression of glk (Table S8).  glk was downregulated in ePtsHIcrr02/04 compared to uPtsHIcrr 
and ePtsHIcrr01/03, but remained upregulated compared to Ref (Table S4).  The mutation 
appeared to tune the expression of glk in order to balance the consumption of ATP with 
sufficient generation of glucose 6-phosphate 3.  
Cell division defects triggered the Rcs Two Component system 
In addition to slow growth, morphological changes were observed when sampling and 
cultivating uPtsHIcrr (data not shown).  Expression profiling revealed extensive upregulation of 
nlpI in uPtsHIcrr compared to Ref (Table S4).  Overexpression of nlpI has been shown to lead to 
morphological changes that are indicative of cell division defects 45,46.  In combination with small 
heat shock proteins IbpA and IbpB, NlpI interrupts nucleoid division and assembly of FtsZ at the 
septum 46.  FtsZ forms a ring at the future replication site, which is the start of the first processes 
of cell division 47.  Additionally, in combination with the periplasmic protease Prc, NlpI forms a 
proteolytic system that regulates peptidoglycan synthesis by degrading MepS.  MepS is a 
murein endopeptidase that participates in expansion of the peptidoglycan by breaking 
peptidoglycan cross links to allow for meurin incorporation 48,49.  A decrease in MepS activity 
through overexpression of nlpI would lead to defective peptidoglycan synthesis. 
 
Expression profiling also revealed that peptidoglycan synthesis abnormalities were detected by 
the Rcs phosphorelay system in uPtsHIcrr.  The Rcs phosphorelay system responds to outer 
member (OM) and peptidoglycan-related stress 50–53, and controls genes related to motility, 
biofilm formation, virulence, pH, osmolarity, periplasmic quality control, cell division, and DNA 
replication 53–55 (Fig. 8A, see caption for mechanistic details of the Rcs phosphorelay system).  
Major Rcs signalling components comprising rcsA, rcsB, rcsC, and rcsD were all upregulated in 
uPtsHIcrr compared to Ref, and in particular, rcsA, which positively upregulates itself upon 
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activation, was massively upregulated (Fig. 8D, Table S4).  Overactivation of the Rcs system is 
lethal 56.    
Synergistic mutations between yrfF and rcs genes deactivate the 
Rcs system 
Overactivation of the Rcs phosphorelay system was negated by synergistic mutations in yrfF 
and rcs genes in all ePtsHIcrr strains (Fig. 8).  yrfF was mutated in all ePtsHIcrr strains (Fig. 8B, 
D).  YrfF constitutively inhibits the autophosphorylation of RcsC and subsequent 
phosphorylation of RcsD by RcsC.  YrfF inactivation allows RcsD to phosphorylate and activate 
RcsB and RcsA, which activate downstream target genes. Combinations of mutation in rcsA, 
rcsB, and rcsD were found in all ePtsHIcrr strains (Fig. 8B, C, D) that complemented the yrfF 
mutations that could have prevented activation of RcsB and RcsA.  
LexA-mediated SOS response duplicated ATP synthase genes 
The loss of ptsHIcrr genes also resulted in a lexA-mediated SOS response 57 (Fig. 9A-B).   The 
SOS response upregulated a plethora of DNA repair genes as well as genes known to increase 
the probability of introducing mutations into the genome (Fig. 9A-C, Table S4).  Significantly 
upregulated genes in uPtsHIcrr included recA, lexA, dinB encoding polymerase IV, ruvABC 
involved in DNA double stranded break repair, and several others (Fig. 9C, Table S4).  
Overexpression of dinB has been shown previously to confer a mutator phenotype 58,59.  The 
peptides encoded by the ruvABC operons form an enzymatic complex called the “resolvasome”, 
which function together to resolve Holliday junctions formed during the recombinational repair of 
damaged double strand DNA, and to rescue blocked DNA replication forks via replication fork 
reversal 60,61. 
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The lexA-mediated SOS response manifested in a large duplication that included the ATP 
synthase complex in ePtsHIcrr02/04 (Fig. 9D-F).  The duplicated region included 139 genes, 
among which 31.7 and 20.9% were doubled in expression compared to uPtsHIcrr and 
ePtsHIcrr01/03, respectively.  Significantly up-regulated genes in ePtsHIcrr02/04 compared to 
uPtsHIcrr included cyaA and all ATP synthase complex genes (Fig. 9F, Table S4). The 
increased gene dosage of ATP synthase complex genes most likely contributed to the 
significant increase in the energy charge that was found in ePtsHIcrr02/04.   
Energy balance shifted flux into and out of the pep node 
Non-intuitively, the loss of flux through the PTS significantly increased the levels of pyruvate in 
ePtsHIcrr01 and ePtsHIcrr03.  pyr levels increased by 870.9 and 1029.2% in ePtsHIcrr01/03 
over Ref.  The largest consuming flux of pep shifted from the PTS to PYK in all uPtsHIcrr and 
ePtsHIcrr strains.    37.9, 122, 143, 92.7, 93.4, 126% of flux per mol of glucose of pep was 
converted to pyr via PYK in Ref, uPtsHIcrr, and ePtsHIcrr strains, respectively (Fig. 5B).  The 
increase in pyr also increased the levels of L-alanine (ala-L), which is produced from pyr in a 
single nitrogen transfer step via glutamate-pyruvate aminotransaminase encoded by alaA or 
alaC 62.  ala-L levels increased by 310.8 and 375.5% in ePtsHIcrr01/03 over Ref.   In addition, 
excess pyr was excreted as Lactate (Fig. 1D, Table S2).  This in particular would have been 
advantageous to the ePtsHIcrr01/03 strains to help rebalance the ratios of NAD and NADH 
which were significantly shifted to the oxidized state compared to ePtsHIcrr02/04 strains (Table 
S3) due to a higher glycolytic flux (Table S6).   
 
The second largest drain of pep shifted from PYK to PPC.  16.0, 55.2, 12.0, 55.5, 22.2, 24.4% 
of flux per mol of glucose of pep was diverted into the TCA cycle through PPC in Ref, uPtsHIcrr, 
and ePtsHIcrr strains, respectively (Fig. 5B).  Including the contributions from PPC, 
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ePtsHIcrr02/04 strains had a significantly greater amount of flux through the TCA cycle.  The 
increased flux through the TCA cycle would be advantageous in the ePtsHIcrr02/04 strains in 
particular for contributing additional redox potentials to the electron transport chain to 
complement the increased dosage of ATP synthase.  In contrast, ePtsHIcrr01/03 strains had 
significantly less TCA cycle flux, but significant acetate excretion (Fig. 1D, Table S2).  This 
would be advantageous in the ePtsHIcrr01/03 strains for regenerating ATP through Acetate 
Kinase. 
 
Conclusion 
In this study, a desirable phenotype for biotechnology applications (i.e., high intracellular AAA 
levels) was lost in all strains but one during ALE.  Mutations were found that altered regulation 
of CCR and secondary glucose import and catabolism pathways in order to restore glucose 
uptake from the loss of the primary glucose import and catabolism route via the PTS.  The 
energy drain caused by the use of secondary glucose import and catabolism pathways was 
offset by changes in flux through glycolysis, lactate and acetate secretion, TCA cycle usage, 
and a duplication of the ATP synthase complex.  From these genetic and physiological 
adaptations emerged a high glycolytic clade (ePtsHIcrr01/03) and a high respiratory clade 
(ePtsHIcrr02/04).  Only the ePtsHIcrr03 strain from the high glycolytic clade retained high levels 
of intracellular AAAs, however all strains retained high levels of AAA biosynthetic precursors.   
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Fig. 1 Evolution of knockout (KO) strains from a pre-evolved (i.e., 
optimized) wild-type strain.  A)  Wild-type (wt) E. coli (MG1655 K-
12) was previously evolved on glucose minimal media at 37
o
C
31
.  
An isolate from the endpoint of the evolutionary experiment was 
selected as the starting strain for subsequent KO of ptsHIcrr and 
adaptive laboratory evolution (ALE).  B) Adaptive laboratory 
evolution trajectories of the evolved knockout lineages.  -Omics 
data collected included metabolomics, fluxomics, physiology, 
DNA resequencing, and transcriptomics.  C) The Glucose specific 
phosphotransferase system (GLCptspp) was disabled by the 
gene KO.  GLCptspp is the primary importer of glucose into the 
cell, and converts glucose to glucose 6 phosphate (g6p) by 
phosphotransfer from Phosphoenolpyruvate (pep) to Pyruvate 
(pyr).    D) Growth rate and uptake and secretion rates for 
unevolved KO (uPtsHIcrr) and evolved KOs (ePtsHIcrr).  For 
comparison, The reference strain (Ref) had a growth rate of 0.92 
(+/- 0.01) hr
-1
 and glucose uptake and acetate secretion rates of -
12.0 (+/- 0.12), 8.18 (+/- 0.15) mmol*gDCW
-1
*hr
-1
, respectively.  
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Fig. 2 KO of the primary glucose importation system (ptsHIcrr) 
increased the availability of PEP for aromatic metabolite 
production, but caused a drain in available ATP through the 
upregulation of secondary glucose importation systems that utilize 
ATP instead of PEP.  A) A network and mechanistic schematic of 
the PTS system. The metabolite conversions in red are removed 
through the ptsHIcrr KO. B) A schematic of passive/active glucose 
importers.  C) Metabolite concentrations of the aromatic amino 
acids L-phenylalanine (phe-L), L-tryptophan (trp-L), and L-tyrosine 
(tyr-L), and their precursor phosphoenolpyruvate (pep) taken from 
3 biological replicates analyzed in duplicate (n=6).  Also shown 
are the metabolite concentrations for L-histidine (his-L), which is 
derived from ribose,  and energy charge ratio calculated as 
     
   
 
            
.  See Fig. S1 for levels of aromatic amino acid 
pathway intermediate levels.  The box represent the interquartile 
ranges, the line through the box represents the median, and 
whiskers represent the maximum and minimum ranges. 
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Fig. 3  Carbon catabolite repression (CCR) in the absence of crr.  Carbon catabolite 
repression is a global regulatory mechanism that inhibits the expression of genes involved in the 
catabolism of secondary carbon sources in the presence of a preferred carbon source.  A)  
Schematic of components and their interactions involved in CCR.  During normal growth on 
glucose, EIIA, encoded by crr, interacts with EIIB, encoded by PtsG, by transferring a 
phosphate group to EIIB.   Thus, during normal growth, EIIB is primarily phosphorylated while 
EIIA is primarily unphosphorylated.  In the absence of glucose, EIIA remains primarily 
phosphorylated (See 63 for a review).  Phosphorylated EIIA in the presence of an unidentified 
effector, positively regulates adenylate cyclase (AC) activity 39,40.  Activation of AC increases 
cAMP levels 36.  cAMP activates CRP,  which triggers myriad transcriptional regulatory changes 
involved in CCR as well as other cellular processes 64.  B) Regulatory diagram of selected 
components involved in CCR.  C) Shift in expression towards galactose symporter and ABC 
transporter, and glucokinase.  gatYZABCD is regulated primarily by CRP-cAMP due to an 
insertion of IS3E in the gatR gene35.  gatYZABCD serves as a reporter of CRP-cAMP activation. 
Fig. 4  Mutations in cyaA that help restore basal levels of cAMP.  A) Schematic of the cyaA 
operon and network diagram of cyaA.  cyaA encodes Adenylate Cyclase (AC), which converts 
ATP to cAMP36.  B) Crystal structure of cyaA.  Deletion (DEL) at the 456 residue in ePtsHIcrr01 
and mobile element insertion (MOB) at the 518 residue target the catalytic region of AC.  Both 
mutations truncate the peptide at the EIIA binding domain.  Mutations are highlighted in red.  
The catalytic region is highlighted in purple.  The crr interaction domain and truncated region are 
highlighted in pink.  C) Mutation frequency and expression profiles of cyaA.  Box and whiskers 
plot of cAMP metabolite concentrations from biological triplicates measured in analytical 
duplicate (n=6).  Besides the significantly different metabolite levels of cAMP between the Ref 
and uPtsHIcrr strain, ePtsHIcrr03 has significanlty less (p<0.05) cAMP than ePtsHIcrr04.  The 
box represent the interquartile ranges, the line through the box represents the median, and 
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whiskers represent the maximum and minimum ranges.  Given the decreased expression of 
cyaA in uPtsHIcrr, the location of the mutations that specifically cleaved cyaA at the crr binding 
domain, and the removal of crr, it would appear that there is another mechanism by which cyaA 
can be activated to produce cAMP.   
Fig. 5 Flux sum through Phosphoenolpyruvate (pep).  A) Network 
diagram of the fluxes into and out of the pep node.  B) Measured 
absolute fluxes.  C) Relative expression levels. 
Fig. 6 Mutations that alter regulation of the D-galactose symporter and D-galactose ABC 
transporter. Expression of the D-galactose symporter (galP) and D-galactose ABC transporter 
(mglBAC) are increased by mutations that target galP and galR.  A) Crystal structure of GalR.  
The SNP in galR in ePtsHIcrr04 occurred in the small molecule binding domain.  Mutations are 
highlighted in red.  The small molecule binding domain is highlighted in cyan.  The H-T-H DNA-
binding region is highlighted in violet.  Note that ePtsHIcrr04 has the highest expression of 
galETKM and mglBAC.  B) Schematic of the galP operon.  The galP SNP occurred at the GalR 
and GalS transcription factor binding sites.  Note that ePtsHIcrr02 has the highest expression of 
galP.  C)  Network schematic of CRP-cAMP, GalR, and GalS transcription factor regulation.  D) 
Mutation frequency, metabolite concentration of cAMP, and expression levels of crp, galR, galS, 
and genes composing the D-galactose symporter and D-galactose ABC transporter. 
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Fig. 7  Mutations that alter regulation of the nAcGam import and 
catabolism.  A) schematic of the nagBAC and nagE operons.  B) 
Crystal structure of NagC.  NagC is a transcription factor that 
inhibits expression of nagBAC and nagE operons.  Location of the 
nagC SNP is highlighted in red.  The H-T-H DNA-binding domain 
is highlighted in cyan.  C) Mutation frequency and expression 
levels of genes encoding nAcGam catabolic enzymes (nagBAC) 
and nAcGam PTS-specific component (nagE).  Note that 
ePtsHIcrr04 has the highest expression of nagBAC and nagE. 
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Fig. 8  yrfF and rcs synergistic inactivation.  A) Schematic of the 
interactions of rcsF, yrfF, rcsC, rcsD, and rcsB that compose the 
Rcs phosphorelay system
56
.  The Rcs phosphorelay system 
responds to outer member (OM) and peptidoglycan-related stress 
in enterobacteria
50–53
, and controls genes related to motility, 
biofilm formation, virulence, pH, osmolarity, periplasmic quality 
control, cell division, and DNA replication
53–55
.  RcsF is an OM 
lipoprotein that senses envelope stress and activates the 
signalling cascade via interaction with YrfF.   Under non OM or 
peptidoglycan-related stress, RcsF is spatially segregated from 
other Rcs components by BamA, a component of the beta-barrel 
assembly machinery, which funnels RcsF through the Beta-barrel 
OmpA.  When the cell wall is damaged, RcsF is no longer 
sequestered by BamA, and RcsF interacts with inner membrane 
(IM) bound YrfF.  YrfF constitutively inhibits the 
autophosphorylation of RcsC and subsequent phosphorylation of 
RcsD by RcsC.  RcsF interaction with YrfF prevents this inhibition 
allowing RcsD to phosphorylate and activate RcsB and RcsA, 
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which activate downstream target genes.  B) yrfF is an essential 
gene in E. coli
65
, and inhibits activation of the Rcs phosphorelay 
system
56
.  Overactivation of the Rcs phosphorelay system leads 
to acid intolerance.  In addition, a yrfF mutant is only viable when 
combined with deletions in rcsB, rcsC, and rcsD that inactivate 
the RCS system
56
.  B) Mutations in yrfF in ePtsHIcrr01 and 03 
that were most likely deleterious.  The frameshift deletion in yrfF 
in ePtsHIcrr01 most likely led to a peptide aggregate, and the 
SNP in ePtsHIcrr03 led to a truncated peptide.   The mobile 
element insertion (MOB) in yrfF in ePtsHIcrr02 and 04 appeared 
to silence gene expression.  the MOB insertion in rcsA in 
ePtsHIcrr02 led to a nonsense mutation.  The MOB insertion in 
rcsD in ePtsHIcrr04 led to a nonsense mutation.  C) Crystal 
structure of RcsB 
66
.  SNPs in rcsB ePtsHIcrr01 targeted the 
receiver and the H-T-H LuxR-type DNA binding domain
53
 (T195A) 
and the response regulator receiver domain (Y73H).  The SNP in 
rcsB ePtsHIcrr03 targeted the H-T-H LuxR-type DNA binding 
domain
53
.  Mutations are highlighted in red.  D) Mutation 
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frequency and gene expression of yrfF, and Rcs phosphorelay 
components.  
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Fig. 9 Knockout of ptsHIcrr induced a lexA-mediated SOS 
response 
57
 (Panels A-C).  A) Under normal physiological 
conditions, LexA represses the expression of its own operon, 
recA, and SOS responder operons.  B) When DNA is damaged, 
single stranded DNA (ssDNA) binds to recA subunits to form a 
protease.  This protease cleaves LexA, leading to a decrease in 
LexA repression, and expression of SOS responder operons.  C) 
Expression profiles of recA, lexA, and SOS response genes that 
are regulated by LexA.  The lexA-mediated SOS response 
manifested into a large chromosomal duplication event that 
resulted in an increased gene dosage of ATP synthase complex 
genes that most likely aided in restoring the energy charge 
(Panels D-F).  D) Reads vs. genome position.  Inset highlights the 
duplicated region near 4MB.  E) Schematic of the ATP synthase 
operon genes.  F) Expression levels of the ATP synthase complex 
genes.  ePtsHIcrr02/04 ATP synthase genes are significantly 
elevated; note that the energy charge for ePtsHIcrr02/04 is not 
significantly different than Ref. 
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Highlights:  
● PTS Knockout-out in E. coli and adaptive laboratory evolution (ALE) 
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● Energy deficiency overcome by high fermentation or respiration.    
● Synergist mutations deactivated the Rcs phosphorelay system aided recovery of fitness 
● High intracellular aromatic metabolite levels found in evolved strains. 
 
